Home Aminos 4-(Butylamino)benzoic acid

4-(Butylamino)benzoic acid

CAS No.:
4740-24-3
Catalog Number:
AG003K6P
Molecular Formula:
C11H15NO2
Molecular Weight:
193.2423
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
250mg
98%(HPLC)
In Stock USA
United States
$73
- +
1g
95%
In Stock USA
United States
$102
- +
5g
95%
In Stock USA
United States
$300
- +
10g
95%
In Stock USA
United States
$525
- +
Product Description
Catalog Number:
AG003K6P
Chemical Name:
4-(Butylamino)benzoic acid
CAS Number:
4740-24-3
Molecular Formula:
C11H15NO2
Molecular Weight:
193.2423
MDL Number:
MFCD00002536
IUPAC Name:
4-(butylamino)benzoic acid
InChI:
InChI=1S/C11H15NO2/c1-2-3-8-12-10-6-4-9(5-7-10)11(13)14/h4-7,12H,2-3,8H2,1H3,(H,13,14)
InChI Key:
YCCRFDDXAVMSLM-UHFFFAOYSA-N
SMILES:
CCCCNc1ccc(cc1)C(=O)O
UNII:
KGL80FSD2F
NSC Number:
44300
Properties
Complexity:
174  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
193.11g/mol
Formal Charge:
0
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
193.246g/mol
Monoisotopic Mass:
193.11g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
49.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.4  
Literature
Title Journal
Inhibition of sensory neuronal TRPs contributes to anti-nociception by butamben. Neuroscience letters 20120111
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
The local anesthetic butamben inhibits total and L-type barium currents in PC12 cells. Anesthesia and analgesia 20080601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives. Pharmaceutical research 20060501
The block of total and N-type calcium conductance in mouse sensory neurons by the local anesthetic n-butyl-p-aminobenzoate. Anesthesia and analgesia 20050601
Prediction of genotoxicity of chemical compounds by statistical learning methods. Chemical research in toxicology 20050601
Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p-aminobenzoate, a promising anesthetic for the treatment of chronic pain. The Journal of pharmacology and experimental therapeutics 20030201
A sudden death following tetracaine-induced spinal anesthesia. Legal medicine (Tokyo, Japan) 20020301
Distribution of tetracaine and its metabolite in rabbits after high versus normal spinal anesthesia. Forensic science international 20011227
Blood concentrations of tetracaine and its metabolite following spinal anesthesia. Forensic science international 20010201
Simultaneous determination of mepivacaine, tetracaine, and p-butylaminobenzoic acid by high-performance liquid chromatography. Journal of pharmacological and toxicological methods 20010101
Properties